Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Office of Research & Development

print icon sign up for VA Research updates

VA Lung Precision Oncology Program (LPOP)


Nearly 8,000 Veterans are diagnosed and treated in VA for lung cancer each year. An estimated 900,000 are at risk for lung cancer due to age, smoking, and environmental exposures during and after military service. Veterans have a higher rate of lung cancer and a lower rate of survival than the general population.

The VA Lung Precision Oncology Program (LPOP), a component of the VHA’s Precision Oncology Initiative, aims to give VA clinicians a range of tools to proactively address and treat lung cancer in Veterans. Precision oncology uses patients’ unique genetic profiles from their tumor to tailor individualized treatment and connect them with new therapies through clinical trials. The program goals include:

  • Prioritizing screening to identify early-stage lung cancer in high-risk Veterans
  • Offering genetic testing for Veterans with advanced lung cancer
  • Improving access for Veterans with advanced lung cancer to precision-oncology clinical trials
  • Increasing the number of clinical trials available to provide Veterans with new treatment options for lung cancer
  • Enabling rapid translation of discoveries into clinical care

To achieve these goals, VA has selected locations across the nation to serve as centralized hub sites. These sites will coordinate with local VA facilities regarding screening, genetic testing, and participation in clinical trials to ensure that Veterans, regardless of where they live, have access to cutting-edge oncology care.

VA Lung Precision Oncology Program (LPOP) Distributed Network of Sites

LPOP Hub Site Locations




Project Director


VA Connecticut Healthcare System

West Haven, Connecticut

Hillary Cain


James J. Peters VA Medical Center

New York, New York

Susan Bates


VA Pittsburgh Healthcare System

Pittsburgh, Pennsylvania

James Herman


Richmond VA Medical Center

Richmond, Virginia

Howard Li


W. G. Hefner VA Medical Center

Salisbury, North Carolina

Jimmy Ruiz


Durham VA Medical Center

Durham, North Carolina

Scott Shofer


Ralph H. Johnson VA Medical Center

Charleston, South Carolina

Nichole Tanner


Miami VA Healthcare System

Miami, Florida

Gregory Holt


Louisville VA Medical Center

Louisville, Kentucky

Fred Hendler


VA Ann Arbor Healthcare System

Ann Arbor, Michigan

Nithya Ramnath


Jesse Brown VA Medical Center

Chicago, Illinois

Lawrence Feldman


St. Louis VA Medical Center

St. Louis, Missouri

Theodore Thomas


Michael E. DeBakey VA Medical Center

Houston, Texas

Farrah Kheramand


VA North Texas Health Care System

Dallas, Texas

Jonathan Dowell


South Texas Veterans Health Care System

San Antonio, Texas

Jonathan Dowell


VA Eastern Colorado Health Care System

Denver, Colorado

Robert Keith


VA Puget Sound Healthcare System

Seattle, Washington

Daniel Wu


San Francisco VA Medical Center

San Francisco, California

Sunny Wang


VA Long Beach Healthcare System

Long Beach, California

Pankaj Gupta


VA Greater Los Angeles Healthcare System

Los Angeles, California

Steven Dubinett


Minneapolis VA Medical Center

Minneapolis, Minnesota

Mark Klein


Omaha VA Medical Center

Omaha, Nebraska

Apar Ganti


Computer Vision and Machine Learning in Precision Oncology (CoMPL)

Cleveland, Ohio

Nithya Ramnath


*Note: CoMPL provides support to all LPOP locations.


LPOP is addressing lung cancer by improving screening, expanding care availability, and developing innovative new treatments. Specific initiatives that are part of LPOP include the following:

  • LPOP utilizes data analytics captured in the Cancer Care Registry to assess Veterans’ quality of care and access nationwide.
  • The VA Partnership to Increase Access to Lung Cancer Screening (VA-PALS) is a multidisciplinary group of clinicians and computer scientists working to increase access to lung screening programs.
  • The VALOR (VA Lung Cancer and Stereotactic Radiotherapy) trial is a phase-three randomized clinical trial investigating the role of high-precision radiation therapy as an alternative to surgery for early-stage lung cancer.
  • LPOP is using TeleOncology to increase access to care for Veterans who live long distances from VA facilities or who have difficulty traveling.

  • Nearly 8,000 Veterans diagnosed with lung cancer each year
  • About 5,000 die from lung cancer each year
  • Around 900,000 Veterans who should be screened for lung cancer due to increased risk
  • 23 LPOP hub locations across the country to coordinate care and research
  • More than 100 locations across VA where Veterans receive chemotherapy
  • Nearly 5,000 Veterans have undergone molecular testing for lung precision oncology as of May 20, 2021

Questions about the R&D website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.